Background/Aims: To evaluate follicular phase antral follicle count (AFC) in women of different ages with and without polycystic ovaries (PCO) and to correlate it with early follicular phase serum follicle stimulating hormone (FSH), estradiol, and ovarian volume. Methods: Retrospective analysis of 1,003 patients’ medical records at McGill Reproductive Center. AFC, ovarian volume, serum FSH and estradiol were evaluated and analyzed. Results: The mean numbers of AFC in women without PCO in the age-groups 19–24, 25–29, 30–34, 35–39, 40–44 years were 16, 13, 13, 10, and 6, and in those with MCO 41, 38, 33, 33 and 34 respectively. In women without MCO, AFC was associated with the strongest correlation with age (r: –0.50, p < 0.0001), followed by basal FSH (r: 0.33, p <0.0001). The correlations in women with PCO were less pronounced (AFC, r: –0.24, p < 0.0001; basal FSH, r: 0.17, p < 0.004). Conclusions: Compared to women without PCO, age-related decreases in AFC and changes in ovarian volume and FSH levels in women with PCO are less pronounced.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.